Bioassay of phenformin for possible carcinogenicity / Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute ; [prepared at Tracor Jitco under the direction of J.F. Robens, with the assistance of G.L. Miller and L.A. Waitz].

Author/creator Carcinogenesis Program (National Cancer Institute (U.S.)).
Format Electronic
Publication InfoWashington, D.C. : U.S. Dept. of Health, Education and Welfare, Public Health Service, National Institutes of Health, 1977.
Description1 online resource (ix, 90 pages) : illustrations.
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo23366
Subjects

Other author/creatorMiller, G. L.
Other author/creatorWaitz, L. A.
Other author/creatorRobens, J. F.
Other author/creatorNational Institutes of Health (U.S.)
SeriesDHEW publication ; no. (NIH) 77-807
Carcinogenesis technical report series ; no. 7
DHEW publication no. (NIH) 77-807. ^A204
National Cancer Institute carcinogenesis technical report series ; no. 7. ^A1107162
General noteTitle from title screen (viewed on May 30, 2012).
General note"The Chemical Abstracts Service (CAS) Registry Number used to track this bioassay is 834-28-6, which is determined to best define the material used in the conduct of this bioassay."
General note"CAS No. 114-86-3."
General note"NCI-CG-TR-7."
Bibliography noteIncludes bibliographical references (p. 47).
Issued in other formNational Cancer Institute (U.S.). Carcinogen Bioassay and Program Resources Branch. Bioassay of phenformin for possible carcinogenicity
Technical rpt#CAS No. 114-86-3
Technical rpt#834-28-6
Technical rpt numberNCI-CG-TR-7
GPO item number0507-G-12 (online)
Govt. docs number HE 20.3159/2:7

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available